Diabetes CME Conferences | Endocrinology

Conferences|Global Meetings| Dubai| UAE| Europe | USA |

2016 | 2017
Clinical Diabetes and Diagnostic Approaches
Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia resulting from
defects in insulin secretion, insulin action, or both. The chronic hyperglycemia of diabetes is
associated with long-term damage, dysfunction, and failure of various organs, especially the eyes,
kidneys, nerves, heart, and blood vessels.
Diabetic kidney disease is recognized as the leading cause of excess mortality in the population with
type 1 diabetes. The prevailing theory is that excess calories are processed via the mitochondria
resulting in accumulation of superoxide radicals via the electron transfer chain.Novel Paradigms in
Diabetic Complications, Diabetes, Pre-diabetes represents an elevation of plasma glucose above the
normal range but below that of clinical diabetes.Prediabetes and Metabolic Syndrome, To better
study both the pathogenesis and potential therapeutic agents, appropriate animal models of type 2
diabetes (T2D) mellitus are needed forClinical trials on animal models, sodium glucose co-transport
inhibitors act asa novel strategy for the treatment of diabetes mellitus
Type 2 diabetes is by far the most common type of diabetes in adults (>90 percent) and is
characterized by hyperglycemia and variable degrees of insulin deficiency and resistance inClinical
presentation and diagnosis of diabetes mellitus in adults.
Related conferences:
Diabetes Conferences Europe September 15-17, 2016, Germany;11th International Conference and
Exhibition onTargeting Diabetesand Novel Therapeutics October 17-19 2016,Malaysia; 9th
GlobalDiabetologistsAnnual Meeting and Medicare Expo June 06-08 2016, USA;8th Euro
GlobalDiabetesSummit and Medicare Expo November 03-05 2015, Spain;10th
EuropeanDiabetesCongress July 14-16 2016, Germany; 7th Indo GlobalDiabetesSummit and
Medicare Expo November 23-25, 2015,India; Physiology,pathophysiologyand future treatment
options for diabetic complications December 7 2015,UK;Pediatric endocrinesociety annual meeting
April 29 2016, USA;Obesityand Adipose Tissue Biology February 15-19 2016, Canada; 18th
International Conference on Diabetes andImmunologyMay 23-24 2016, UK;Pediatric
endocrinesociety annual meeting April 29 2016, USA;Obesityand Adipose Tissue Biology February
15-19 2016, Canada; ISN World Congress ofNephrologyApril 21-25 2017, Mexico
Diabetes Management
People with type 1 ortype 2 diabetesare diagnosed with more of some types ofcancer-- and are more
likely to die fromcancer-- than people withoutdiabetes, a new Australian study shows.
The brain is a hugely important organ which helps to be aware of, understand and interact with our
surroundings and others.
As with many of our organs, the brain is susceptible to damage as a result ofdiabetes & brain

Diabetes foot care & management: Foot ulcers and amputations are a major cause of morbidity,
disability, as well as emotional and physical costs for people with diabetes. Early recognition and
management of independent risk factors for ulcers and amputations can prevent or delay the onset
of adverse outcomes.
In Cardiac Resynchronization TherapyArrhythmias are irregular heart rhythms and can be caused by
a variety of reasons, including age, heart damage, medications and genetics. In heart failure patients
CRT, or biventricular pacing, is used to help improve the hearts rhythm and the symptoms
associated with the arrhythmia.
Implantable Cardioverter DefibrillatorAn ICD is a battery-powered device placed under the skin that
keeps track of your heart rate. Thin wires connect the ICD to your heart. If an abnormal heart
rhythm is detected the device will deliver an electric shock to restore a normal heartbeat if your
heart is beating chaotically and much too fast. It is important to understand that the decision to
haveangioplastyorcoronary artery bypass graft (CABG) surgeryto treatcoronary artery disease
(CAD)depends on many different things. A healthful eating pattern, regularphysical activity, and
often pharmacotherapy are key components ofdiabetes management. It is best to get vitamins and
minerals from the foods you eat. In fact, research has not been able to prove that dietary orherbal
supplements(including omega-3 supplements, cinnamon, and other herbs) help to manage diabetes.
Related conferences:
12thDiabetesMeeting and Therapeutics Expo September 29-1st october 2016, Canada;11th Asia
PacificDiabetesConferenceand Expo July 11-13 2016,Australia; 6th GlobalDiabetesSummit and
Medicare Expo November 02-04 2015, UAE; 15th GlobalDiabetesSummit and Medicare Expo
November 14-16 2016, UAE; International Conference onTargeting Diabetesand Novel Therapeutics
September 14-16 2015,USA; The 5th World Congress on Controversies to Consensus in Diabetes,
Hypertension andObesityNovember 05-07, 2015,Turkey; 43rd Meeting of the British Society
forPaediatric Endocrinologyand Diabetes November 25-27 2015, UK; DiabeticRetinopathy-Battling
the Global Epidemic September 27 2015, USA; , European Association for the Study ofDiabetesEye
Complications Study Group 26th Annual Meeting June 16-18 2016, UK; International Conference
onMetabolic SyndromesOctober 20-22, 2016,UAE; Diabetes Conferences Europe September 15-17,
2016, Germany
Diabetes and its complications
Gastro paresisis a disorder affecting people with both type 1 andtype 2 diabetesin which the
stomach takes too long to empty its contents (delayed gastric emptying)Diabetic retinopathyis the
most common diabetic eye disease and a leading cause of blindness in American adults. It is caused
by changes in the blood vessels of theretina.Diabetic neuropathyis a type of nerve damage that can
occur if you have diabetes. High blood sugar can injure nerve fibers throughout your body,
butdiabetic neuropathymost often damages nerves in your legs and feet. Currently, diabetic
nephropathy is the leading cause of chronic kidney disease in the United States and other Western
societies. It is also one of the most significant long-term complications in terms of morbidity and
mortality for individual patients with diabetes. Diabetes is responsible for 30-40% of all end-stage
renal disease (ESRD) cases in the United States.
Cardiomyopathyis a condition where the heart muscle is abnormal. The main types of
cardiomyopathy include dilated, hypertrophic and restrictive cardiomyopathy. Cardiomyopathy
makes it harder for your heart to pump and deliver blood to the rest of your body. Cardiomyopathy
can lead to heart failure.Latent autoimmune diabetes in adults(LADA) is a disorder in which, despite

the presence of islet antibodies at diagnosis of diabetes, the progression of autoimmune -cell failure
is slow.
Hypoglycemiais amedical emergencythat involves an abnormally diminished content ofglucosein
theblood. Pregnant women who have never had diabetes before but who have highblood
glucose(sugar) levels during pregnancy are said to havegestational diabetes. According toa 2014
analysis by the Centers for Disease Control and Prevention, theprevalenceofeuglycemia gestational
diabetes conferencesis as high as 9.2%. High blood pressure orhypertensionincreases the risk of
heart disease and stroke. Hypertension risk factors include obesity, drinking too much alcohol,
smoking, and family history. Beta-blockers are a common treatment for hypertension.

Related conferences:
9th GlobalDiabetologistsAnnual Meeting and Medicare Expo June 06-08 2016,USA ; 11th Asia
PacificDiabetesConferenceand Expo July 11-13 2016,Australia; 6th GlobalDiabetesSummit and
Medicare Expo November 02-04 2015, UAE; 15th GlobalDiabetesSummit and Medicare Expo
November 14-16 2016, UAE;Diabetes Conferences Europe September 15-17, 2016, Germany; 11th
International Conference and Exhibition on TargetingDiabetesand Novel Therapeutics October 17-19
2016,Malaysia;Minnesota Midwest AACE Annual Meeting onendocrinologyNovember 21st 2015,
USA;Mid-Atlantic AACE 13th Annual meeting onEndocrinologySep 25-26 2015, USA; AACE New
England annual meeting onendocrinologyNovember 14th 2015, Marlborough;Pediatric
endocrinesociety annual meeting April 29 2016, USA;Obesityand Adipose Tissue Biology February
15-19 2016
Advanced Technologies & Treatments for Diabetes
Blood glucose (bloodsugar) monitoringis the main tool you have to check your diabetes control. This
check tells you yourbloodglucoselevelat any one time. Theartificial pancreasbridges the gap between
two pieces of diabetes technology that already exist: the insulin pump and the continuous glucose
monitor (CGM).Relatively, a large percentage of world population is affected by diabetes mellitus,
out of which approximately 5-10% with type 1 diabetes while the remaining 90% with type 2.Insulin
administrationis essential for type 1 patients while it is required at later stage by the patients of type
2. Currentinsulin delivery systemsare available as transdermal injections which may be considered
as invasive. Several non-invasive approaches for insulin delivery are being pursued by
pharmaceutical companies to reduce the pain, and hypoglycemic incidences associated with
injections in order to improve patient compliance.
Related conferences:
6th GlobalDiabetesSummit and Medicare Expo November 02-04 2015, UAE; 15th
GlobalDiabetesSummit and Medicare Expo November 14-16 2016, UAE; International Conference
onTargeting Diabetesand Novel Therapeutics September 14-16 2015,USA;9th
GlobalDiabetologistsAnnual Meeting and Medicare Expo June 06-08 2016, USA; Euro
GlobalDiabetesSummit and Medicare Expo November 03-05 2015, Spain; New Therapeutics for
Diabetes andObesityApril 17-20, 2016 USA; Diabetes Conferences Europe September 15-17, 2016,
Germany; InternationalConference onDiabetesMellitusSeptember 18-20 2015, China;Pediatric
endocrinesociety annual meeting April 29 2016, USA;Obesityand Adipose Tissue Biology February
15-19 2016; ; International Conference onMetabolic SyndromesOctober 20-22, 2016,UAE

Advancement of New Drug/Biomarker Discovery for Treatment of Diabetes

As aprognostic biomarkerfor progression of diabetic nephropathy, albuminuria fails in terms of
sensitivity and specificity. Better urinary or plasma biomarkers are needed that can predict which
diabetic patients are at highest risk for progression. Bhensdadiaet al.report proteomic investigations
that identified urinary haptoglobin as a potential prognostic biomarker for progressive diabetic
nephropathy. Although as a single marker urinary haptoglobin adds little to albuminuria, together
the two appear to provide better diagnostic accuracy thanalbuminuriaalone. Excess adiposity is the
most important risk factor for the development of insulin resistance and type 2 diabetes (1).
However, mechanisms whereby body fat induces insulin resistance in distant tissues are not well
understood. Recent evidence indicates that obesity may be aninflammatory markers.
Related conferences
8th Euro GlobalDiabetesSummit and Medicare Expo November 03-05 2015, Spain; 12th
EuropeanDiabetes Congress September 15-17 2016 Berlin, Germany; Diabetes Conferences Europe
September 15-17, 2016, Germany; 7th Indo GlobalDiabetesSummit and Medicare Expo November
23-25 2015, India; 9th GlobalDiabetologistsAnnual Meeting and Medicare Expo June 06-08
2016,USA; 12thDiabetesMeeting and Therapeutics Expo September 29-October 1 2016, Canada;
Indian Society ofOrgan TransplantAnnual meeting October 2-4 2015, India; Joint congress of the
InternationalPancreasand Islet transplant association and International Xenotransplant Association
and Cell Transplant society November 15-19 2015, Australia; American society oftransplantsurgeons
16th state of the art winter symposium January 14-17, 2016, USA, 14th Basic Science Symposium of
theTransplantationSociety November 11-13 2015, Australia; WorldDiabetesCongress(WDC)
November 30- December- 04 2015,Canada
Genetics of Diabetes
Several factors have to come together for a person to develop type 2 diabetes. Elements like
nutrition and exercise are extremely important. However, type 2 diabetes also has a
stronggeneticcomponent. Diabetes constitutes a major public health problem. Although substantial
progress has been made in defining the genetic risk for specific subtypes of diabetes
The burden of diabetes is much higher for racial/ethnic minorities than for whites. Minorities have a
higher prevalence of diabetes than whites, and some minorities have higher rates of diabetes-related
complications and death. Research results help in understanding these disparities and ways to
reduce them.
Diabetes, the sixth leading cause of death in the United States, is a chronic disease characterized
bypersistent hyperglycemia(high blood glucose levels). ignificant advances have been made in
recent years in relation to the pathogenesis of T2DM. This has significantly improved our knowledge
of one of the most serious health threats in the world, allowing identification of genes and pathways
involved in the development and progression of the disease. It has recently become possible to
acquiremolecular and genetic levelinformation from an individual.
Related conference:
15th GlobalDiabetesSummit and Medicare Expo November 14-16 2016, UAE; International
Conference on TargetingDiabetesand Novel Therapeutics September 14-16 2015,USA;9th
GlobalDiabetologistsAnnual Meeting and Medicare Expo June 06-08 2016, USA; 8th Euro
GlobalDiabetesSummit and Medicare Expo November 03-05 2015, Spain;10th European

DiabetesCongressJuly 14-16 2016, Germany;Healthand Nutrition Conference Oct 26-28 2015,USA;

New Zealand Society for the Study ofDiabetesAnnual Scientific Meeting May 4-6 2016, New
Zealand;15th International Conference: Ayurveda &AutoimmuneDisordersOctober 9-11 2015, USA; ;
International Conference onMetabolic SyndromesOctober 20-22, 2016,UAE; Study ofDiabetesEye
Complications Study Group 26th Annual Meeting June 16-18 2016, UK; Diabetes Conferences
Europe September 15-17, 2016, Germany
Emerging Focus in Diabetes Research
Dyslipidemiais one of the major risk factors for cardiovascular disease in diabetes mellitus. The
characteristic features of diabetic dyslipidemia are a high plasma triglyceride concentration, low
HDL cholesterol concentration and increased concentration of small dense LDL-cholesterol particles.
There are many risk factors for type 2 diabetes such as age, race, pregnancy, stress, certain
medications, genetics or family history, high cholesterol and obesity. However, the single best
predictor of type 2 diabetes is overweight or obesity. Almost 90% of people living with type 2
diabetes are overweight or haveobesity. People who are overweight or have obesity have added
pressure on their body's ability to use insulin to properly control blood sugar levels, and are
therefore more likely to develop diabetes. The number of diabetes cases among American adults
increased by a third during the 1990s, and additional increases are expected. This rapid increase in
the occurrence of diabetes is mostly attributed to the growing prevalence of obesity in the United
States.
The Bioinformatics/ComputationalBiology Service branch will provide basic capabilities to the Joslin
Diabetes Center to analyze a wide range of high-throughput data. Housed on-site at the Joslin, the
group and associated resources will be available to Joslin investigators and fellows who are either
planning high-throughput experiments or need analysis of multi-scale data.
We prospectively followed 51,552 Finnish men and women 2574 years of age without a history
ofParkinson's diseaseat baseline. History of diabetes and other study parameters were determined at
baseline using standardized measurements. Ascertainment of the Parkinson's disease status was
based on the nationwide Social Insurance Institution's drug register data. Hazard ratios of incident
Parkinson's disease associated with the history of type 2 diabetes were estimated. The entire
spectrum ofdiabesity, including all of its complicationsdiabetes, elevated blood sugar, blood
pressure, andcholesterolare simply downstream symptoms that result fromproblems with diet,
lifestyle, and environmental toxins interacting with our unique genetic susceptibilities.Bariatric
surgerymay be an option for adults with severe obesity. Body mass index (BMI), a measure of height
in relation to weight, is used to define levels of obesity. Clinically severe obesity is a BMI > 40 or a
BMI > 35 with a serious health problem linked to obesity. Such health problems could be type 2
diabetes, heart disease, or severe sleep apnea (when breathing stops for short periods during sleep).
Related conferences:
7th International Conference onBiomarkers& Clinical Research November 28-30 2016 , USA; 7th
Indo GlobalDiabetesSummit and Medicare Expo November 23-25, 2015, India; 6th
GlobalDiabetesSummit and Medicare Expo November 02-04 2015, UAE; International Conference on
TargetingDiabetesand Novel Therapeutics September 14-16, 2015, USA; 11th International
Conference and Exhibition on TargetingDiabetesand Novel Therapeutics October 17-19, 2016,
Malaysia; Diabetes Conferences Europe September 15-17, 2016, Germany;
TheBiomarkerConference February 18 - 19 2016, USA; 2ndBiomarkersConference 2016 September
19-20 2016, UK;BiomarkerSummit March 2016, USA;18th International Conference onDiabetesand

Metabolism February 25-26 2016,UK; DiabeticRetinopathy-Battling the Global Epidemic September

27 2015, USA
Transplantation for Diabetes
In pancreatic islet transplantation, cells are taken from a donor pancreas and transferred into
another person. Once implanted, the new islets begin to make and release insulin. Researchers hope
thatislet transplantationwill help people with type 1 diabetes live without daily injections of
insulin.Xenotransplantationis thetransplantationof livingcells,tissuesororgansfrom onespeciesto
another. Such cells, tissues or organs are calledxenograftsorxenotransplants.
A transplant of the pancreas is usually reserved for those with seriouscomplications. Pancreas
transplantsare most often done when a patient also receives a new kidney.Beta cell regeneration
eventspancreas transplant adds little further risk in this situation and offers big benefits. However,
transplant surgery is risky. Each person needs to carefully weigh the potential benefits and risks.
Related conferences:
Diabetes Conferences Europe September 15-17, 2016, Germany; 3rd International Conference
onEndocrinologyNovember 02-04, 2015,USA; 2nd Global Summit onHormonesand Steroids June 2325 2016, USA; 9th GlobalDiabetologistsAnnual Meeting and Medicare Expo June 06-08, 2016, USA;
International Conference onMetabolic SyndromesOctober 20-22, 2016,UAE; International
Conference on TargetingDiabetesand Novel Therapeutics September 14-16, 2015,USA;25th Annual
Meeting and Clinical Congress of the American Association of ClinicalEndocrinologistsMay 25-29
2016, USA; , 55th Annual Meeting of the European Society forPaediatric EndocrinologySeptember
10-12 2016, France;Pediatric endocrinesociety annual meeting April 29 2016, USA;Obesityand
Adipose Tissue Biology February 15-19 2016, Canada; International Conference onMetabolic
SyndromesOctober 20-22, 2016,UAE
Endocrinology: Disorders & Treatment
The endocrine system is a network of glands that produce and release hormones that help control
many important body functions, especially the body's ability to change calories into energy that
powers cells and organs. The endocrine system influences how yourheartbeats, how your bones and
tissues grow, even your ability to make a baby. It plays a vital role in whether or not you
developdiabetes,thyroiddisease, growth disorders, sexual dysfunction, and a host of other hormonerelated disorders.
Related conferences:
4th International Conference and Exhibition onObesityand Weight Management December 07-09,
2015, USA; 5th International conference and Exhibition onObesity& Weight Management December
05-07 2016, USA; 11th Asia PacificDiabetesConferenceand Expo July 11-13 2016; Diabetes
Conferences Europe September 15-17, 2016, Germany; 6th GlobalDiabetesSummit and Medicare
Expo November 02-04 2015, UAE; International Conference onTargeting Diabetesand Novel
Therapeutics September 14-16, 2015, USA; 18th International Conference onFood Science,
Nutritional Health and Medicine September 21-22 2016,UAE; 13th International Congress
onObesityMay 1-4 2016, Canada; ,Pediatric endocrinesociety annual meeting April 29 2016,
USA;Obesityand Adipose Tissue Biology February 15-19 2016, Canada; 18th
InternationalConference on DiabetesandImmunologyMay 23-24 2016, UK

Cell Therapy for Diabetes and Its Complications

Pancreatic -cellsare the target of an autoimmune assault in type 1 diabetes, with invasion of the
islets by mononuclear cells in an inflammatory reaction termed insulitis, leading to loss of most -cells
after prolonged periods of disease.

Stem cellsare essentially undifferentiated cells that can

be induced into becoming specialized cells that are
tissue- or organ-specific, according to the U.S. National
Institutes of Health.
In some cases, such cells are sourced from embryonic
tissue. Alternatively, it's possible to derive stem cells
from prespecialized adult cells that are then
reprogrammed to morph into an undifferentiated state.
These are called induced pluripotent stem cells.
Related conferences:
6th International Conference onNephrology& Therapeutics September 29-October 01 2016, USA;
7th Indo GlobalDiabetesSummit and Medicare Expo November 23-25, 2015, India; 6th
GlobalDiabetesSummit and Medicare Expo November 02-04 2015, UAE; International Conference
onTargeting Diabetesand Novel Therapeutics September 14-16, 2015, USA; 11th International
Conference and Exhibition onTargeting Diabetesand Novel Therapeutics October 17-19, 2016,
Malaysia;World Congress oninsulin resistance, diabetes and cardiovascular disease November 19-21
2015, USA; Diabetes Conferences Europe September 15-17, 2016, Germany; 16th MalvernDiabetic
FootConference May 18-20 2016, UK; ISN World Congress ofNephrologyApril 21-25 2017, Mexico;
DiabeticRetinopathy-Battling the Global Epidemic September 27 2015, USA; , European Association
for the Study ofDiabetesEye Complications Study Group 26th Annual Meeting June 16-18 2016, UK
Diabetes has increasingly become a lifestyle-related disease as it afflicts young and old. According to
WHO Diabetes was estimated to affect 371 million people till the end of 2011in US. Whereas, new
figures indicate that the number of people living with diabetes is expected to rise from 371 million in
2012 to 552 million by 2030. This indicates an urgent alarm for its management.
"Regionally, we saw the largest increase in diagnosed diabetes prevalence in the South, followed by
the West, Midwest, and Northeast," with CDC's Division of Diabetes Translation and lead author of
the report. "These data also reinforce findings from previous studies, which indicate that the
prevalence of diagnosed diabetes is highest in the southern and Appalachian states."
As the number of patients grows across the globe, there has never been a stronger and more urgent
need for therapeutic measures that arrest the growth of the disease and alleviate its secondary
manifestations. In Type 1 diabetes total -cell loss occurs. In Type 2 diabetes, partial -cell loss occurs
before diagnosis, and the progressive -cell loss during the life of the patient increases the severity of
the disease. This addresses novel therapies for these deficiencies in clinical and preclinical
evaluation.
Many International Conferences and Diabetic therapies meetings/ symposium and workshops have
been organized on different topics related to the risk factors related to diabetes across the globe

such as glucose tolerability conference, diabetes stem cell cure conference, anti-diabetic agents
meetings, obesity conferences, weight loss conferences, Islet transplantation international
conference, glucose variability conferences etc. Besides that many international events such as
diabetes alternative medicines events, insulin pump therapy events, pancreatic dysfunction events,
recombinant approaches for diabetes events etc. Targeted Therapy Events have been also taking
place in order to find a weapon against fatal diseases like diabetic foot, insulin resistance, glucose
tolerability, obesity and to discuss the role of diabetes in cardiovascular diseases, kidney diseases,
risk of cancer and intolerability to cure the wound which will gives a better insight about the
associated causes and disease portfolio.
Why in Dubai
The UAE has the second-highest diabetes rate in the world, with an estimated 20% of residents and
25% of nationals suffering from the disease. Nearly three-quarters of diabetes patients in the UAE
do not have their diabetes under control, a challenge particularly pronounced among children and
young adults. It is estimated that 40 to 50% of diabetics in the UAE are unaware they even have the
disease. Left unchecked, the spread of diabetes portends devastating social and fiscal consequences,
including threats to economic progress and investment stability in the region.
The United Arab Emirates (UAE) has achieved an impressive level of economic development. In
particular, its healthcare sector is among the best performing in the world. By many measures of
health status (infant mortality, life expectancy, eradication of numerous infectious diseases), the
UAE has reached levels comparable with other developed nations. In addition, the health
infrastructure which includes facilities, equipment, and staff, are of high quality. This healthcare is
offered freely or at low-cost to citizens and highly subsidised to residents and tourists. The fact that
the UAE has made such great strides in achieving a high level of excellence in accommodating the
healthcare needs of so many people is a testament to wise resource management policies. However,
at least one health pandemic threatens to unravel the systems stability: diabetes. The World Health
Organization (WHO) and the International Diabetes Federation (IDF) call diabetes the 21st centurys
leading healthcare challenge. Diabetes complications and mortality create social and economic
challenges that affect individuals, families, businesses, and society as a whole. Six Middle East North
Africa (MENA) region countries Bahrain, Egypt, Kuwait, Oman, Saudi Arabia, and the United Arab
Emirates (UAE) are among the worlds 10 highest for prevalence of diabetes and impaired glucose
tolerance. By 2020, 32% of the adult UAE population (age 20-79) may have diabetes or pre-diabetes,
while other data indicate that the adult UAE population (ages 18 and above) has already reached a
diabetes or pre-diabetes rate of 44%. If trends continue, the IDF projects that by 2030, the number
of people with diabetes in the Middle East North Africa (MENA) region will almost double, reaching
59.7 million.
Diabetes Associations
Major Diabetes Associations around the Globe

Diabetes Indian Association

Canadian Diabetes Association
International Diabetes Federation

Diabetes Australia
Austrian Diabetes Association
Diabetes UK
Diabetes South Africa
Spanish Diabetes Society (Spain)
Swedish Diabetes Association
Korean Diabetes Association

Major DiabetesAssociations in Dubai

Emirates diabetes society
Global Health Partner Diabetes Centre Dubai
Cleveland Clinic Dubai
Joslin Diabetes Centre Dubai
Al Jalila Foundation Research Centre in Dubai
Diabetes Research Institute Dubai
Diabetes Education in Tribal Schools (DETS)
Imperial College London Diabetes Centre Dubai
http://d3d3lmrpywjldgvzzxhwby5jb2000g00.d3d3lm9tawnzb25saw5llm9yzw0000.d2viy2fjaguuz29vz
2xldxnlcmnvbnrlbnquy29t.d3d3lmdvb2dszs5jb2000.dhjhbnnsyxrllmdvb2dszs5jb2000.d3d3lmdvb2dsz
s5jb2000.cgx1cy5nb29nbguuy29t.d3d3lmzveg5ld3muy29t.yml0lmx5.www.www.foxnews.com/g00/T
U9SRVBIRVVTdW5kZWZpbmVkJGh0dHA6Ly93d3cuZGlhYmV0ZXNleHBvLmNvbS9taWRkbGVlYXN0
Lw%3D%3D/$/$